You are here: Industry Insights > COVID-19 Vaccine

News List

Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds worldpharmanews
October 23, 2020
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety.
EU signs contract with J&J on Covid-19 vaccine candidate pharmaceutical-technology
October 23, 2020
The European Commission (EC) has signed a contract on behalf of European Union (EU) states with Johnson & Johnson (J&J) for the supply of 400 million doses of its Covid-19 vaccine candidate.
UK to collaborate with Oxford Immunotec to evaluate COVID-19 vaccine T cell responses expresspharma
October 23, 2020
T cell immunity is thought to be essential to protect against infection from the SARS-COV-2 coronavirus and could provide longer-term immunity than antibodies.
SARS-CoV-2 vaccine safely induces an immune response in healthy volunteers europeanpharmaceuticalreview
October 22, 2020
The Chinese COVID-19 vaccine candidate BBIBP-CorV elicited an antibody response in all recipients, according to preliminary Phase I/II trial data.
COVID-19 vaccine delivery: Prepping for challenge extraordinaire expresspharma
October 22, 2020
India will have a very strategic role to play in ensuring universal access to COVID-19 vaccines. All stakeholders must step up their game and eliminate chinks in their supply chain and successfully execute this critical task.
AIOCD appeals to PM to utilise their supply chain for COVID-19 vaccine distribution expresspharma
October 22, 2020
The association has requested the PM to instruct concerned authorities to issue guidelines for use of its channel members to distribute COVID-19 vaccines.
ImmunityBio, NantKwest begin patient dosing in Phase 1 clinical trial of COVID-19 vaccine candidate expresspharma
October 22, 2020
The Phase 1 trial, being conducted at the Hoag Hospital in Newport Beach, California, is enrolling healthy adult subjects up to age 55 to examine the safety and reactogenicity of two doses of the vaccine candidate.
Brazil volunteer in AstraZeneca COVID-19 vaccine trial dies, trial to go on expresspharma
October 22, 2020
Sources say that the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.
Chumakov Center initiates Covid-19 vaccine candidate trials pharmaceutical-technology
October 22, 2020
Russia’s Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products has initiated clinical trials of its potential Covid-19 vaccine in St Petersburg.
Medigen, Dynavax COVID-19 Vaccine Receives Taiwan, China Government Subsidy americanpharmaceuticalreview
October 19, 2020
Medigen Vaccine Biologics and Dynavax Technologies announced that MVC has obtained a China's Taiwan, China government subsidy for successfully initiating a Phase 1 clinical trial in Taiwan, China.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page